Mettler-Toledo International, Inc. (NYSE:MTD) Shares Sold by Bessemer Group Inc.

Bessemer Group Inc. reduced its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 73.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,634 shares of the medical instruments supplier's stock after selling 4,479 shares during the period. Bessemer Group Inc.'s holdings in Mettler-Toledo International were worth $1,929,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Asset Management One Co. Ltd. raised its stake in Mettler-Toledo International by 7.8% in the 1st quarter. Asset Management One Co. Ltd. now owns 18,991 shares of the medical instruments supplier's stock valued at $22,427,000 after purchasing an additional 1,382 shares during the last quarter. Kentucky Retirement Systems Insurance Trust Fund acquired a new stake in shares of Mettler-Toledo International in the first quarter valued at about $714,000. North Point Portfolio Managers Corp OH lifted its stake in shares of Mettler-Toledo International by 1.1% in the first quarter. North Point Portfolio Managers Corp OH now owns 9,277 shares of the medical instruments supplier's stock worth $10,955,000 after buying an additional 97 shares in the last quarter. Suncoast Equity Management boosted its position in Mettler-Toledo International by 15.1% during the first quarter. Suncoast Equity Management now owns 586 shares of the medical instruments supplier's stock worth $692,000 after acquiring an additional 77 shares during the last quarter. Finally, Abundance Wealth Counselors grew its stake in Mettler-Toledo International by 8.9% during the 1st quarter. Abundance Wealth Counselors now owns 736 shares of the medical instruments supplier's stock valued at $880,000 after acquiring an additional 60 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company's stock.

Insider Buying and Selling

In related news, Director Michael A. Kelly sold 1,062 shares of the business's stock in a transaction on Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total transaction of $1,231,845.66. Following the completion of the transaction, the director directly owned 120 shares of the company's stock, valued at $139,191.60. The trade was a 89.85% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.77% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

MTD has been the topic of several recent research reports. Wells Fargo & Company boosted their target price on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a report on Monday, May 5th. Bank of America boosted their price objective on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the stock a "neutral" rating in a research note on Thursday, June 26th. Wall Street Zen downgraded Mettler-Toledo International from a "buy" rating to a "hold" rating in a research note on Monday, May 5th. Robert W. Baird lowered their price target on shares of Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating on the stock in a research report on Tuesday, April 22nd. Finally, Citigroup upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 price objective for the company in a research report on Monday, April 7th. Eight equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Hold" and an average price target of $1,300.36.

Mettler-Toledo International Stock Performance

Shares of NYSE MTD traded down $0.74 during trading on Wednesday, reaching $1,204.55. The stock had a trading volume of 89,076 shares, compared to its average volume of 150,050. The company has a market cap of $25.03 billion, a P/E ratio of 30.09, a PEG ratio of 3.61 and a beta of 1.37. Mettler-Toledo International, Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,546.93. The business's 50-day moving average price is $1,142.07 and its 200-day moving average price is $1,196.56.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share for the quarter, beating the consensus estimate of $7.90 by $0.29. The company had revenue of $883.74 million during the quarter, compared to the consensus estimate of $876.61 million. Mettler-Toledo International had a negative return on equity of 556.22% and a net margin of 22.17%. Mettler-Toledo International's revenue was down 4.6% compared to the same quarter last year. During the same period in the previous year, the company posted $8.89 EPS. Analysts forecast that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.